ISBT 2019: Ortho Clinical Diagnostics to Discuss How Full Automation, Data Transfer and Management Can Streamline Lab Operations

ISBT 2019: Ortho Clinical Diagnostics to Discuss How Full Automation, Data Transfer and Management Can Streamline Lab Operations

Jun 22, 2019

See How ORTHO VISION® Platforms Can Deliver Enhanced Patient Care, More Effective Data and Improved Turnaround Time

RARITAN, N.J., and BASEL, Switzerland – Ortho Clinical Diagnostics, a global leader of in vitro diagnostics, will discuss the latest trends and technology in transfusion medicine and introduce its newly installed regional leader for Germany, Austria and Switzerland at the 2019 International Society of Blood Transfusion (ISBT) congress, June 22-26 in Basel.

Ortho will welcome attendees to booth No. 1431 in Conference Center Basel and participate in conversations around the following topics:

  • How a total immunohematology solution combining column agglutination technology, different harmonized automation options and middleware can increase efficiencies in complex networks, including control of your operations from a single, centralized portal.
  • How automation of complex immunohematology testing such as extended phenotype, antibody identification, rare antigen typing and antibody titrations allows you to optimize your resources.
  • How Ortho combines a history of trusted results in immunohematology and infectious disease donor screening with state-of-the-art support tools maximizing the uptime of your laboratory.

Present at the booth will be Ortho’s newly installed managing director responsible for Germany, Austria and Switzerland, Waclaw Lukowicz. Lukowicz has a proven track record of growing and developing international markets across the globe and looks forward to discussing how Ortho solutions can benefit customers in central Europe.

“Ortho is the leader globally in immunohematology with an absolute commitment to serving European markets, so it is a huge honor to represent this company for the first time at such a prestigious transfusion medicine congress right here in Switzerland,” Lukowicz said. “I am excited to meet our customers face to face, and to talk to health care leaders about the key role Ortho can play in Europe’s transfusion services labs.”

On display at Ortho’s booth will be its ORTHO VISION® and ORTHO VISION® Max analyzers, and its full range of immunohematology solutions, as well as the VITROS® 3600 Immunodiagnostic System and its assay menu for infectious disease screening in donors’ blood, including the VITROS® HIV Combo Test and the VITROS® Anti-T. cruzi assay.

For more information and updates from ISBT, follow Ortho on LinkedInTwitterFacebook and Instagram.

About Ortho Clinical Diagnostics
Ortho Clinical Diagnostics is a global leader of in vitro diagnostics serving the clinical laboratory and immunohematology communities. Across hospitals, hospital networks, blood banks and labs in more than 125 countries and territories, Ortho's high-quality products and services enable health care professionals to make better-informed treatment decisions. For the immunohematology community, Ortho's blood typing products help ensure every patient receives blood that is safe, the right type and the right unit. Ortho brings sophisticated testing technologies, automation, information management and interpretation tools to clinical laboratories around the world to help them run more efficiently and effectively and improve patient care. Ortho's purpose is to improve and save lives with diagnostics, and it does that by reimagining what's possible. This is what has defined Ortho for more than 75 years, and it's what drives Ortho forward. For more information, visit www.orthoclinicaldiagnostics.com.

© Ortho Clinical Diagnostics 2019

Press Contact:
Jane Ward
Ortho Clinical Diagnostics
1 908 210 0118
jane.ward@orthoclinicaldiagnostics.com


PR-05161

 

© Ortho Clinical Diagnostics 2019. Ortho Clinical Diagnostics, publishes this site and is solely responsible for its content. The availability of the products is subject to compliance with the regulatory requirements of each market.
${loading}